AvaxNews

Pharmaceutical Executive Joins Mesoblast As Chief Financial Officer – MarketWatch



Pharmaceutical Executive Joins Mesoblast As Chief Financial Officer
MarketWatch
Mesoblast Limited (asx:MSB)(usotc:MBLTY) today announced the appointment of pharmaceutical executive Mr Paul Hodgkinson as Mesoblast Chief Financial Officer. Mr Hodgkinson has broad and high-level international pharmaceutical experience in all ...

and more »

Comments are closed

Поговорим о Кино

Copyright Financial News Focus | White Kitchen | Tax Haven Countries